Roche Holding (RHHBY) presents at Bernstein's 18th Annual Strategic Decisions Conference

Roche: Rejuvenation and Diversification Teresa Graham | Head Pharma Global Product Strategy (GPS) Bernstein SDC Conference Strong portfolio rejuvenation and diversification HY 2016 HY 2011 HY 2021 AHR CHFm CHFm CHFm 21,671 AHR AHR 16,815 19,460 Metabolism/Bone Renal anemia Other Immunology Neuroscience Oncology Ophthalmology Infectious diseases Hemophila A 2 Source: Pharma HY sales as reported in HY reports; AHR=Avastin, Herceptin, MabThera/Rituxan Note: HY 2011 – Inflammation/Autoimmune/Transplantation sho ...